70 related articles for article (PubMed ID: 20188462)
21. Gonadotropin-releasing hormone promotes ovarian cancer cell invasiveness through c-Jun NH2-terminal kinase-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9.
Cheung LW; Leung PC; Wong AS
Cancer Res; 2006 Nov; 66(22):10902-10. PubMed ID: 17108127
[TBL] [Abstract][Full Text] [Related]
22. Phospholipase D and extracellular signal-regulated kinase in hepatic stellate cells: effects of platelet-derived growth factor and extracellular nucleotides.
Benitez-Rajal J; Lorite MJ; Burt AD; Day CP; Thompson MG
Am J Physiol Gastrointest Liver Physiol; 2006 Nov; 291(5):G977-86. PubMed ID: 17030901
[TBL] [Abstract][Full Text] [Related]
23. Ras/ERK signaling pathway mediates activation of the p21WAF1 gene promoter in vascular smooth muscle cells by platelet-derived growth factor.
Lee B; Moon SK
Arch Biochem Biophys; 2005 Nov; 443(1-2):113-9. PubMed ID: 16248979
[TBL] [Abstract][Full Text] [Related]
24. Regulation of monocyte chemoattractant protein-1 by the oxidized lipid, 13-hydroperoxyoctadecadienoic acid, in vascular smooth muscle cells via nuclear factor-kappa B (NF-kappa B).
Dwarakanath RS; Sahar S; Reddy MA; Castanotto D; Rossi JJ; Natarajan R
J Mol Cell Cardiol; 2004 Apr; 36(4):585-95. PubMed ID: 15081318
[TBL] [Abstract][Full Text] [Related]
25. Hepatocyte growth factor-activated NF-kappaB regulates HIF-1 activity and ODC expression, implicated in survival, differently in different carcinoma cell lines.
Tacchini L; De Ponti C; Matteucci E; Follis R; Desiderio MA
Carcinogenesis; 2004 Nov; 25(11):2089-100. PubMed ID: 15240510
[TBL] [Abstract][Full Text] [Related]
26. Caffeic acid phenethyl ester downregulates phospholipase D1 via direct binding and inhibition of NFκB transactivation.
Park MH; Kang DW; Jung Y; Choi KY; Min do S
Biochem Biophys Res Commun; 2013 Dec; 442(1-2):1-7. PubMed ID: 24103753
[TBL] [Abstract][Full Text] [Related]
27. The TSP motif in AP180 inhibits phospholipase D1 activity resulting in increased efficacy of anticancer drug via its direct binding to carboxyl terminal of phospholipase D1.
Cho JH; Oh DY; Kim HJ; Park SY; Choi HJ; Kwon SJ; Lee KS; Han JS
Cancer Lett; 2011 Mar; 302(2):144-54. PubMed ID: 21296491
[TBL] [Abstract][Full Text] [Related]
28. Cell invasion of highly metastatic MTLn3 cancer cells is dependent on phospholipase D2 (PLD2) and Janus kinase 3 (JAK3).
Henkels KM; Farkaly T; Mahankali M; Segall JE; Gomez-Cambronero J
J Mol Biol; 2011 May; 408(5):850-62. PubMed ID: 21414324
[TBL] [Abstract][Full Text] [Related]
29. Rebamipide-induced downregulation of phospholipase D inhibits inflammation and proliferation in gastric cancer cells.
Kang DW; Min G; Park DY; Hong KW; Min do S
Exp Mol Med; 2010 Aug; 42(8):555-64. PubMed ID: 20625243
[TBL] [Abstract][Full Text] [Related]
30. Phospholipase D1 and choline kinase-α are interactive targets in breast cancer.
Gadiya M; Mori N; Cao MD; Mironchik Y; Kakkad S; Gribbestad IS; Glunde K; Krishnamachary B; Bhujwalla ZM
Cancer Biol Ther; 2014 May; 15(5):593-601. PubMed ID: 24556997
[TBL] [Abstract][Full Text] [Related]
31. Role of phospholipase D in migration and invasion induced by linoleic acid in breast cancer cells.
Diaz-Aragon R; Ramirez-Ricardo J; Cortes-Reynosa P; Simoni-Nieves A; Gomez-Quiroz LE; Perez Salazar E
Mol Cell Biochem; 2019 Jul; 457(1-2):119-132. PubMed ID: 30877512
[TBL] [Abstract][Full Text] [Related]
32. PLD1 promotes tumor invasion by regulation of MMP-13 expression via NF-κB signaling in bladder cancer.
Nagumo Y; Kandori S; Tanuma K; Nitta S; Chihara I; Shiga M; Hoshi A; Negoro H; Kojima T; Mathis BJ; Funakoshi Y; Nishiyama H
Cancer Lett; 2021 Jul; 511():15-25. PubMed ID: 33945837
[TBL] [Abstract][Full Text] [Related]
33. Key roles for the lipid signaling enzyme phospholipase d1 in the tumor microenvironment during tumor angiogenesis and metastasis.
Chen Q; Hongu T; Sato T; Zhang Y; Ali W; Cavallo JA; van der Velden A; Tian H; Di Paolo G; Nieswandt B; Kanaho Y; Frohman MA
Sci Signal; 2012 Nov; 5(249):ra79. PubMed ID: 23131846
[TBL] [Abstract][Full Text] [Related]
34. A role for phospholipase D3 in myotube formation.
Osisami M; Ali W; Frohman MA
PLoS One; 2012; 7(3):e33341. PubMed ID: 22428023
[TBL] [Abstract][Full Text] [Related]
35. Novel function of biguanides in inhibition of phospholipase D1 expression via a translational mechanism in cancer cells.
Yao Y; Li H; Wang X; Sun Y; Zhao X; Zha W; Zhou J; Toomre D; Fu J; Xu Y
Genes Dis; 2023 Sep; 10(5):1787-1790. PubMed ID: 37492746
[No Abstract] [Full Text] [Related]
36. Circulating inflammatory cells in patients with metastatic breast cancer: Implications for treatment.
Gianni C; Palleschi M; Schepisi G; Casadei C; Bleve S; Merloni F; Sirico M; Sarti S; Cecconetto L; Di Menna G; Schettini F; De Giorgi U
Front Oncol; 2022; 12():882896. PubMed ID: 36003772
[TBL] [Abstract][Full Text] [Related]
37. Phospholipase D1 promotes cervical cancer progression by activating the RAS pathway.
Song M; Meng Q; Jiang X; Liu J; Xiao M; Zhang Z; Wang J; Bai H
J Cell Mol Med; 2022 Aug; 26(15):4244-4253. PubMed ID: 35775110
[TBL] [Abstract][Full Text] [Related]
38. Aldolase A and Phospholipase D1 Synergistically Resist Alkylating Agents and Radiation in Lung Cancer.
Chang YC; Chang PM; Li CH; Chan MH; Lee YJ; Chen MH; Hsiao M
Front Oncol; 2021; 11():811635. PubMed ID: 35127525
[TBL] [Abstract][Full Text] [Related]
39. Nano-Graphene Oxide-Promoted Epithelial-Mesenchymal Transition of Human Retinal Pigment Epithelial Cells through Regulation of Phospholipase D Signaling.
Park SY; Song WC; Kim B; Oh JW; Park G
Nanomaterials (Basel); 2021 Sep; 11(10):. PubMed ID: 34684987
[TBL] [Abstract][Full Text] [Related]
40. The phospholipase D inhibitor FIPI potently blocks EGF-induced calcium signaling in human breast cancer cells.
Stricker HM; Rommerswinkel N; Keil S; Gnoth SA; Niggemann B; Dittmar T
Cell Commun Signal; 2021 Apr; 19(1):43. PubMed ID: 33832505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
